347 related articles for article (PubMed ID: 27042741)
1. ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.
Camacho PM; Mazhari AM; Wilczynski C; Kadanoff R; Mumm S; Whyte MP
Endocr Pract; 2016 Aug; 22(8):941-50. PubMed ID: 27042741
[TBL] [Abstract][Full Text] [Related]
2. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia.
Gagnon C; Sims NA; Mumm S; McAuley SA; Jung C; Poulton IJ; Ng KW; Ebeling PR
J Clin Endocrinol Metab; 2010 Mar; 95(3):1007-12. PubMed ID: 20089612
[TBL] [Abstract][Full Text] [Related]
3. Adult hypophosphatasia treated with teriparatide.
Whyte MP; Mumm S; Deal C
J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adult hypophosphatasia with teriparatide.
Camacho PM; Painter S; Kadanoff R
Endocr Pract; 2008 Mar; 14(2):204-8. PubMed ID: 18308659
[TBL] [Abstract][Full Text] [Related]
5. Adult hypophosphatasia treated with reduced frequency of teriparatide dosing.
Polyzos SA; Tournis S; Goulas A; Kollia P; Whyte MP
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):584-589. PubMed ID: 34854399
[TBL] [Abstract][Full Text] [Related]
6. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
Genest F; Seefried L
Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
[TBL] [Abstract][Full Text] [Related]
7. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
Sutton RA; Mumm S; Coburn SP; Ericson KL; Whyte MP
J Bone Miner Res; 2012 May; 27(5):987-94. PubMed ID: 22322541
[TBL] [Abstract][Full Text] [Related]
8. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
Righetti M; Wach J; Desmarchelier R; Coury F
Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and fracture risk in adult patients with hypophosphatasia.
Genest F; Claußen L; Rak D; Seefried L
Osteoporos Int; 2021 Feb; 32(2):377-385. PubMed ID: 32879991
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic.
Desborough R; Nicklin P; Gossiel F; Balasubramanian M; Walsh JS; Petryk A; Teynor M; Eastell R
Bone; 2021 Mar; 144():115795. PubMed ID: 33301960
[TBL] [Abstract][Full Text] [Related]
11. Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.
Sadhukhan S; Mehta P; Rajender S; Gupta SK; Chattopadhyay N
Osteoporos Int; 2022 Dec; 33(12):2479-2493. PubMed ID: 35776147
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia.
Schalin-Jäntti C; Mornet E; Lamminen A; Välimäki MJ
J Clin Endocrinol Metab; 2010 Dec; 95(12):5174-9. PubMed ID: 20739387
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
16. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood.
Khandwala HM; Mumm S; Whyte MP
Endocr Pract; 2006; 12(6):676-81. PubMed ID: 17229666
[TBL] [Abstract][Full Text] [Related]
17. Atypical femoral fracture in a 51-year-old woman: Revealing a hypophosphatasia.
Maman E; Briot K; Roux C
Joint Bone Spine; 2016 May; 83(3):346-8. PubMed ID: 26992955
[TBL] [Abstract][Full Text] [Related]
18. Asfotase alfa improved skeletal mineralization and fracture healing in a child with MCAHS.
Kang M; Wu M; Crane JL
Bone; 2023 Jul; 172():116778. PubMed ID: 37088336
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Teriparatide Treatment on Fracture Healing Complications and Symptomatic Bone Marrow Edema in Four Adult Patients With Hypophosphatasia.
Schmidt T; Rolvien T; Linke C; Jandl NM; Oheim R; Amling M; Barvencik F
JBMR Plus; 2019 Aug; 3(8):e10215. PubMed ID: 31485555
[TBL] [Abstract][Full Text] [Related]
20. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
